These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
332 related articles for article (PubMed ID: 34848831)
1. Expression of B7 family checkpoint proteins in cervical cancer. Zong L; Gu Y; Zhou Y; Kong Y; Mo S; Yu S; Xiang Y; Chen J Mod Pathol; 2022 Jun; 35(6):786-793. PubMed ID: 34848831 [TBL] [Abstract][Full Text] [Related]
2. Expression and Significance of Immune Checkpoints in Clear Cell Carcinoma of the Uterine Cervix. Zong L; Zhang Q; Zhou Y; Kong Y; Yu S; Chen J; Zhang Y; Xiang Y J Immunol Res; 2020; 2020():1283632. PubMed ID: 32322590 [TBL] [Abstract][Full Text] [Related]
3. Expression and Prognostic Value of B7 Family Immune Checkpoints in Pancreatic Neuroendocrine Tumors. Mo S; Zong L; Chen X; Ban X; Li M; Lu Z; Yu S; Chen J Arch Pathol Lab Med; 2023 Feb; 147(2):193-201. PubMed ID: 35671167 [TBL] [Abstract][Full Text] [Related]
4. Expression and clinical significance of PD-L1, B7-H3, B7-H4 and VISTA in craniopharyngioma. Wang Y; Deng J; Wang L; Zhou T; Yang J; Tian Z; Yang J; Chen H; Tang X; Zhao S; Zhou L; Tong A; Xu J J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32958683 [TBL] [Abstract][Full Text] [Related]
5. VISTA expression is associated with a favorable prognosis in patients with high-grade serous ovarian cancer. Zong L; Zhou Y; Zhang M; Chen J; Xiang Y Cancer Immunol Immunother; 2020 Jan; 69(1):33-42. PubMed ID: 31781843 [TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of Programmed Death Ligand-1 in Discriminating Patients With Lymph Node-Negative, p53-Wild-Type, or Low-BRCA1/2-Expression Pancreatic Ductal Adenocarcinoma. Chen X; Zhang Y; Mo S; Ma H; Lu Z; Yu S; Chen J Arch Pathol Lab Med; 2023 Apr; 147(4):465-473. PubMed ID: 35862858 [TBL] [Abstract][Full Text] [Related]
7. Expression and clinical significance of VISTA and PD-L1 in adrenocortical carcinoma. Zhang Z; Li M; Wang J; Liu M; Chen H; Lou Y; Wang Y; Sun Q; Zhu D; Li P; Bi Y Endocr Relat Cancer; 2022 May; 29(7):403-413. PubMed ID: 35521773 [TBL] [Abstract][Full Text] [Related]
8. Expression of the immune checkpoint VISTA in breast cancer. Zong L; Mo S; Yu S; Zhou Y; Zhang M; Chen J; Xiang Y Cancer Immunol Immunother; 2020 Aug; 69(8):1437-1446. PubMed ID: 32266446 [TBL] [Abstract][Full Text] [Related]
9. B7-H3 immune checkpoint expression is a poor prognostic factor in colorectal carcinoma. Lu Z; Zhao ZX; Cheng P; Huang F; Guan X; Zhang MG; Chen HP; Liu Z; Jiang Z; Zheng ZX; Zou SM; Wang XS Mod Pathol; 2020 Nov; 33(11):2330-2340. PubMed ID: 32514163 [TBL] [Abstract][Full Text] [Related]
10. Expression and clinical significance of VISTA, B7-H3, and PD-L1 in glioma. Wang LC; Wang YL; He B; Zheng YJ; Yu HC; Liu ZY; Fan RR; Zan X; Liang RC; Wu ZP; Tang X; Wang GQ; Xu JG; Zhou LX Clin Immunol; 2022 Dec; 245():109178. PubMed ID: 36368642 [TBL] [Abstract][Full Text] [Related]
11. PD-L1, B7-H3 and VISTA are highly expressed in gestational trophoblastic neoplasia. Zong L; Zhang M; Wang W; Wan X; Yang J; Xiang Y Histopathology; 2019 Sep; 75(3):421-430. PubMed ID: 31013360 [TBL] [Abstract][Full Text] [Related]
12. Analysis of the OX40/OX40L immunoregulatory axis combined with alternative immune checkpoint molecules in pancreatic ductal adenocarcinoma. Chen X; Ma H; Mo S; Zhang Y; Lu Z; Yu S; Chen J Front Immunol; 2022; 13():942154. PubMed ID: 35936015 [TBL] [Abstract][Full Text] [Related]
13. Expression of B7-H3 Correlates with PD-L1 and Poor Prognosis in Patients with Cervical Cancer. Zhang Q; Zong L; Zhang H; Xie W; Yang F; Sun W; Cui B; Zhang Y Onco Targets Ther; 2021; 14():4275-4283. PubMed ID: 34326649 [TBL] [Abstract][Full Text] [Related]
14. B7-H3 Expression in NSCLC and Its Association with B7-H4, PD-L1 and Tumor-Infiltrating Lymphocytes. Altan M; Pelekanou V; Schalper KA; Toki M; Gaule P; Syrigos K; Herbst RS; Rimm DL Clin Cancer Res; 2017 Sep; 23(17):5202-5209. PubMed ID: 28539467 [No Abstract] [Full Text] [Related]
15. Expression of B7-H3 and TIM-3 in gastric-type endocervical adenocarcinoma: prevalence, association with PD-L1 expression, and prognostic significance. Sun Y; Zhou X; Lucas E; Chen L; Zhang H; Chen H; Zhou F J Pathol Clin Res; 2024 Jan; 10(1):e345. PubMed ID: 37798754 [TBL] [Abstract][Full Text] [Related]
16. PD-L1, B7-H3, and PD-1 expression in immunocompetent vs. immunosuppressed patients with cutaneous squamous cell carcinoma. Varki V; Ioffe OB; Bentzen SM; Heath J; Cellini A; Feliciano J; Zandberg DP Cancer Immunol Immunother; 2018 May; 67(5):805-814. PubMed ID: 29484464 [TBL] [Abstract][Full Text] [Related]
17. V-domain Ig-containing suppressor of T-cell activation (VISTA), a potentially targetable immune checkpoint molecule, is highly expressed in epithelioid malignant pleural mesothelioma. Muller S; Victoria Lai W; Adusumilli PS; Desmeules P; Frosina D; Jungbluth A; Ni A; Eguchi T; Travis WD; Ladanyi M; Zauderer MG; Sauter JL Mod Pathol; 2020 Feb; 33(2):303-311. PubMed ID: 31537897 [TBL] [Abstract][Full Text] [Related]
18. Expression of the inhibitory B7 family molecule VISTA in human colorectal carcinoma tumors. Xie S; Huang J; Qiao Q; Zang W; Hong S; Tan H; Dong C; Yang Z; Ni L Cancer Immunol Immunother; 2018 Nov; 67(11):1685-1694. PubMed ID: 30128738 [TBL] [Abstract][Full Text] [Related]
19. Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC). Carvajal-Hausdorf D; Altan M; Velcheti V; Gettinger SN; Herbst RS; Rimm DL; Schalper KA J Immunother Cancer; 2019 Mar; 7(1):65. PubMed ID: 30850021 [TBL] [Abstract][Full Text] [Related]
20. Prognostic effect of different PD-L1 expression patterns in squamous cell carcinoma and adenocarcinoma of the cervix. Heeren AM; Punt S; Bleeker MC; Gaarenstroom KN; van der Velden J; Kenter GG; de Gruijl TD; Jordanova ES Mod Pathol; 2016 Jul; 29(7):753-63. PubMed ID: 27056074 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]